Related Experiment Video

Updated: Aug 22, 2026

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN
11:50

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN

Published on: April 3, 2026

Evidence for transcriptional repression of SPARC-like 1, a gene downregulated in human lung tumors

Silvia G Isler1, Christian U Ludwig, Ruth Chiquet-Ehrismann

  • 1Friedrich Miescher Institute, Novartis Research Foundation, Maulbeerstrasse 66, CH-4058 Basel, Switzerland.

International Journal of Oncology
|September 18, 2004
PubMed

Insights

SPARCL1 is downregulated in non-small cell lung cancer (NSCLC) and other carcinomas. Researchers found no mutations, suggesting SPARCL1 is not a classical tumor suppressor gene, but may be downregulated by transcriptional repression involving exon 1.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • SPARCL1 mRNA is downregulated in non-small cell lung cancer (NSCLC) and other carcinomas, suggesting a tumor suppressor role.
  • Previous investigations proposed SPARCL1 as a tumor suppressor gene due to its reduced expression in various cancers.

Purpose of the Study:

  • To investigate the mechanism behind SPARCL1 downregulation in NSCLC.
  • To determine if SPARCL1 is a classical tumor suppressor gene affected by deletions or mutations.
  • To explore the role of transcriptional regulation in SPARCL1 downregulation.

Main Methods:

  • Microsatellite analysis, real-time quantitative PCR, and sequence analysis of SPARCL1 exons and promoter regions.
  • Luciferase reporter gene assays using 10 different SPARCL1 promoter constructs.
  • Analysis of exon 1's ability to inhibit gene expression when transferred to a heterologous promoter.

Main Results:

  • No deletions or mutations in SPARCL1 exons or the promoter region were found in NSCLC.
  • Luciferase assays indicated that the presence of exon 1 reduces reporter gene activity.
  • The inhibitory effect of exon 1 was transferable to a different promoter, confirming its regulatory function.

Conclusions:

  • SPARCL1 does not appear to be a classical tumor suppressor gene inactivated by deletion or mutation in NSCLC.
  • SPARCL1 downregulation is likely mediated, at least in part, by trans-acting factors binding to exon 1, suggesting transcriptional repression.
  • These findings highlight a novel mechanism of gene regulation in cancer involving specific exonic sequences.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...